Yi Zhao

9PUBLICATIONS
20CO-AUTHORS
Haematological tumoursPredictive and prognostic markersPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 15, 2025
Incidence, Prognostic Factors, and Treatment Impact on Survival in Natural Killer/T-Cell Lymphoma: Population-Based Study in the United States.

Yi Zhao, Yi Zhong, Mengqi Xiong

|Jul 23, 2024
TP53 and KMT2D mutations associated with worse prognosis in peripheral T-cell lymphomas.

Lingling Wang, Lei Yang, Fangshu Guan

|May 03, 2024
Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China.

Xiaoyan Han, Xincheng Jiang, Jingsong He

|Mar 11, 2024
Pre-treatment [18F]FDG PET/CT for assessing bone marrow involvement and prognosis in patients with newly diagnosed peripheral T-cell lymphoma.

Jing Chen, Yi Zhao

|Feb 05, 2024
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective study.

Fangshu Guan, Luxin Yang, Yi Chen

|Feb 03, 2023
Cytomegalovirus and Epstein-Barr virus infection during daratumumab treatment in patients with multiple myeloma.

Shuchan Li, Gaofeng Zheng, Jingsong He

Pageof 2

Frequent Collaborators

3 joint publications

Jingsong He

3 joint publications

Zhen Cai

1 joint publications

Jiasheng Wang

1 joint publications

Yujie Zhang